7 results
RIPE Therapy - Drug Regimens for Microbiologically Confirmed Pulmonary Tuberculosis - IDSA Guidelines

#Tuberculosis #ActiveTB #RIPE #Therapy
Microbiologically Confirmed Pulmonary ... IDSA Guidelines ... #ActiveTB #RIPE ... #medications #pharmacology ... #IDSA #Guidelines
IDSA - Prophylaxis to Prevent First Episode of Opportunistic Disease in HIV-AIDS
 • Pneumocystis pneumonia (PCP)
Mycobacterium tuberculosis ... infection (TB) ... Infections #OIs #HIVAIDS ... #IDSA #management ... #pharmacology
IDSA - Prophylaxis to Prevent First Episode of Opportunistic Disease in HIV-AIDS
 • Pneumocystis pneumonia (PCP)
Mycobacterium tuberculosis ... infection (TB) ... Infections #OIs #HIVAIDS ... #IDSA #management ... #pharmacology
IDSA Recommendations for Treating Mycobacterium Tuberculosis Infection and Disease in HIV-AIDS
Treating LTBI (to prevent TB disease)
Indications:
Adolescent ARV Guidelines ... #TB #IDSA #Prevention ... #Treatment #management ... opportunistic #infections #HIVAIDS ... #pharmacology
IDSA - Clinical Strategy to Build an Individualized Treatment Regimen for Multi-Drug Resistant Tuberculosis (MDR-TB)
 •
IDSA - Clinical ... medical consultation ... #MDRTB #management ... antimicrobials #regimens #pharmacology ... #dosing #idsa #
Immune Reconstitution Inflammatory Syndrome - Overview of IRIS

What Is IRIS?
	• A state of hyperinflammatory response that
a few months (median ... , pulmonary infiltrates ... • Persistently active ... meningitis • Guidelines ... Differential #Diagnosis #Management
IDSA Recommendations for Preventing and Treating Disseminated Mycobacterium Avium Complex in HIV-AIDS
Preventing 1st Episode of Disseminated
IDSA Recommendations ... Note: Active TB ... Prevention #Treatment #management ... opportunistic #infections #HIVAIDS ... #pharmacology